<metadata>
# Discovery Questions: Genomic Sequence Processing & Analysis

- **Pattern Number:** 26
- **Pattern Name:** Genomic Sequence Processing & Analysis
- **Document Type:** Discovery Questions
- **Created Date:** 2025-08-13
- **Version:** 1.0
</metadata>

---

<discovery_current_state>
## Discovery & Current State Assessment

1. **What sequencing platforms and technologies are you currently using, and what is your typical genomic data processing volume per month?**
   - *Purpose: Assess current sequencing capacity, technology mix, and scale requirements for processing infrastructure*

2. **How do you currently manage your genomic data processing workflows, and what are the main bottlenecks and challenges in your analysis pipeline?**
   - *Purpose: Understand existing bioinformatics infrastructure, identify performance gaps, and quantify automation opportunities*

3. **What bioinformatics tools and software are you currently using for sequence analysis, variant calling, and genomic annotation?**
   - *Purpose: Evaluate current tool stack compatibility, identify upgrade needs, and plan migration strategies*

4. **How long does it currently take to process a single genome from raw sequence to final results, and what are your turnaround time requirements?**
   - *Purpose: Establish baseline performance metrics and define target performance improvements for new architecture*
</discovery_current_state>

---

<strategy_business_alignment>
## Strategy & Business Alignment

5. **What are your organization's primary genomic analysis objectives, and how do they align with public health surveillance, clinical diagnostics, or research goals?**
   - *Purpose: Align genomic processing capabilities with organizational mission and strategic priorities*

6. **What specific genomic applications are most critical to your mission (pathogen surveillance, population studies, clinical diagnostics, drug resistance monitoring)?**
   - *Purpose: Prioritize platform capabilities and ensure solution meets most critical use cases first*

7. **How do genomic analysis capabilities impact your ability to respond to public health emergencies, support clinical care, or advance research objectives?**
   - *Purpose: Quantify business impact and establish value proposition for high-performance genomic processing*

8. **What funding sources and budget considerations exist for genomic infrastructure modernization and ongoing operational costs?**
   - *Purpose: Understand investment capacity and align solution scope with budget parameters*
</strategy_business_alignment>

---

<opportunity_qualification>
## Opportunity Qualification

9. **What timeline and urgency exist for implementing enhanced genomic processing capabilities, and what factors are driving this need?**
   - *Purpose: Understand project urgency, business drivers, and implementation timeline requirements*

10. **Who are the key stakeholders and decision-makers for genomic infrastructure, bioinformatics platforms, and public health technology initiatives?**
    - *Purpose: Identify buying committee, implementation sponsors, and change management requirements*

11. **What previous experience do you have with cloud-based genomic analysis, high-performance computing, or large-scale bioinformatics implementations?**
    - *Purpose: Assess cloud readiness, technical maturity, and implementation risk factors*

12. **What are your expectations for performance improvement, cost reduction, and operational efficiency gains from modernized genomic processing?**
    - *Purpose: Establish success criteria and ROI expectations for platform implementation*
</opportunity_qualification>

---

<technical_scoping_architecture>
## Technical Scoping & Architecture

13. **What is your current computing infrastructure (on-premises, cloud, hybrid), and what are your preferences for genomic data processing deployment?**
    - *Purpose: Determine deployment architecture preferences and assess infrastructure readiness*

14. **What data storage and management systems do you currently use for genomic data, and what are your long-term data retention requirements?**
    - *Purpose: Plan data migration strategies and design appropriate storage architecture*

15. **Do you have existing high-performance computing resources, and what experience does your team have with HPC cluster management?**
    - *Purpose: Assess current HPC capabilities and determine managed service vs. self-managed preferences*

16. **What network connectivity and bandwidth constraints exist for genomic data transfer and processing workflows?**
    - *Purpose: Design appropriate data transfer mechanisms and assess network infrastructure requirements*

17. **What integration requirements exist with laboratory information systems, electronic health records, or external genomic databases?**
    - *Purpose: Plan comprehensive integration strategy and ensure seamless workflow connectivity*
</technical_scoping_architecture>

---

<genomic_data_workflows>
## Genomic Data & Workflows

18. **What types of genomic sequencing data do you work with (whole genome, exome, targeted panels, metagenomic, viral surveillance)?**
    - *Purpose: Configure appropriate analysis pipelines and optimize processing workflows for specific data types*

19. **What reference genomes, annotation databases, and genomic resources are essential for your analysis workflows?**
    - *Purpose: Ensure access to required reference data and plan for database integration and updates*

20. **How do you currently handle data quality control, contamination detection, and genomic data validation?**
    - *Purpose: Implement appropriate quality assurance frameworks and maintain data integrity standards*

21. **What variant calling, annotation, and interpretation workflows are critical for your genomic analysis objectives?**
    - *Purpose: Configure specialized analysis pipelines and ensure clinical or research-grade accuracy*

22. **Do you require population-level genomic analysis, phylogenetic reconstruction, or epidemiological modeling capabilities?**
    - *Purpose: Design appropriate population genomics tools and surveillance-specific analytics*
</genomic_data_workflows>

---

<regulatory_compliance>
## Regulatory & Compliance

23. **What regulatory requirements apply to your genomic data (HIPAA, GDPR, IRB approvals, biosecurity regulations)?**
    - *Purpose: Ensure compliance with applicable regulations and implement appropriate data protection measures*

24. **How do you currently manage genomic data privacy, de-identification, and secure sharing with collaborators?**
    - *Purpose: Design privacy-preserving analytics and secure collaboration frameworks*

25. **What data sovereignty, geographic restrictions, or cross-border transfer limitations affect your genomic data?**
    - *Purpose: Plan appropriate data residency and ensure compliance with jurisdiction-specific requirements*

26. **What audit trail, documentation, and validation requirements exist for your genomic analysis workflows?**
    - *Purpose: Implement comprehensive audit logging and ensure regulatory compliance documentation*
</regulatory_compliance>

---

<performance_scalability>
## Performance & Scalability

27. **What are your current and projected genomic data processing volumes, and how do you expect these to grow over time?**
    - *Purpose: Design scalable architecture and plan for future capacity requirements*

28. **What performance requirements exist for different types of genomic analysis (real-time surveillance vs. research studies)?**
    - *Purpose: Optimize performance for different use cases and establish appropriate service levels*

29. **Do you require real-time or near-real-time genomic analysis capabilities for outbreak detection or clinical diagnostics?**
    - *Purpose: Design low-latency processing pipelines and real-time surveillance capabilities*

30. **What geographic distribution or multi-site processing requirements exist for your genomic analysis needs?**
    - *Purpose: Plan multi-region deployment and ensure global accessibility*
</performance_scalability>

---

<collaboration_sharing>
## Collaboration & Data Sharing

31. **What external collaborations, data sharing partnerships, or international surveillance networks do you participate in?**
    - *Purpose: Design secure collaboration frameworks and ensure interoperability with partner systems*

32. **How do you currently share genomic data and analysis results with public health agencies, research collaborators, or clinical partners?**
    - *Purpose: Implement appropriate data sharing mechanisms and maintain security controls*

33. **What requirements exist for contributing genomic data to national or international surveillance databases (GISAID, GenBank, etc.)?**
    - *Purpose: Automate data submission workflows and ensure compliance with database requirements*

34. **Do you need capabilities for federated analysis or privacy-preserving multi-party computation for genomic research?**
    - *Purpose: Implement advanced privacy-preserving analytics for sensitive genomic collaborations*
</collaboration_sharing>

---

<operational_processes>
## Operational Processes

35. **How do your laboratory, bioinformatics, and public health teams currently collaborate on genomic analysis projects?**
    - *Purpose: Design collaborative workflows and ensure effective team coordination*

36. **What training, support, and change management will be needed for teams to adopt new genomic processing capabilities?**
    - *Purpose: Plan comprehensive training programs and ensure successful user adoption*

37. **How do you currently monitor genomic data quality, analysis performance, and system health?**
    - *Purpose: Implement appropriate monitoring and alerting systems for genomic operations*

38. **What backup, disaster recovery, and business continuity requirements exist for your genomic analysis operations?**
    - *Purpose: Design robust disaster recovery and ensure continuous operations*
</operational_processes>

---

<public_health_surveillance>
## Public Health & Surveillance

39. **What pathogen surveillance, outbreak detection, or epidemiological analysis capabilities do you require?**
    - *Purpose: Configure surveillance-specific analytics and real-time monitoring capabilities*

40. **How do you currently identify and track emerging variants, antimicrobial resistance, or other genomic markers of public health concern?**
    - *Purpose: Implement automated surveillance algorithms and real-time alert systems*

41. **What integration requirements exist with public health response systems, laboratory networks, or international surveillance programs?**
    - *Purpose: Ensure seamless integration with public health infrastructure and response workflows*

42. **Do you need capabilities for modeling transmission dynamics, contact tracing support, or intervention impact assessment?**
    - *Purpose: Implement epidemiological modeling tools and decision support capabilities*
</public_health_surveillance>

---

<success_metrics>
## Success Metrics & Outcomes

43. **What key performance indicators and metrics will you use to measure the success of enhanced genomic processing capabilities?**
    - *Purpose: Establish measurement framework and track implementation success*

44. **How will you measure the impact of improved genomic analysis on public health outcomes, research productivity, or clinical care?**
    - *Purpose: Define value measurement criteria and demonstrate platform impact*

45. **What reporting and dashboard capabilities are needed for different stakeholder groups (laboratory directors, public health officials, researchers)?**
    - *Purpose: Design appropriate visualization and reporting tools for different user communities*

46. **How do you envision measuring return on investment and cost-effectiveness of modernized genomic processing infrastructure?**
    - *Purpose: Establish ROI measurement framework and track value realization*
</success_metrics>

---

<implementation_readiness>
## Implementation Readiness

47. **What pilot programs, proof-of-concept approaches, or phased implementation strategies would work best for your organization?**
    - *Purpose: Design appropriate implementation approach and minimize deployment risk*

48. **What data migration, system integration, and workflow transition challenges do you anticipate?**
    - *Purpose: Plan comprehensive migration strategy and address potential implementation obstacles*

49. **What ongoing support, maintenance, and enhancement requirements do you expect for genomic processing infrastructure?**
    - *Purpose: Plan long-term operational support and ensure platform sustainability*

50. **How will you ensure knowledge transfer, documentation, and capability sustainment after implementation?**
    - *Purpose: Establish knowledge management and ensure long-term platform success*
</implementation_readiness>

---

*These discovery questions are designed to comprehensively assess genomic processing requirements, understand organizational needs, and ensure successful implementation of high-performance genomic sequence processing and analysis capabilities.*